TransPerfect's GlobalLink Connect integration with Adobe Experience Cloud enabled one of the world’s largest pharmaceutical companies to help visitors in 17 countries and 13 languages identify clinical trials that might be right for them or their loved ones....
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From ethical considerations surrounding patient/caregiver consent, to the intricate timing challenges of data collection, the conversation examines how involvement in a study impacts on disease states and...
Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching the systems to analyze information and improve processes. This is done through data annotation. Discover immediate steps to leverage the power of AI/ML and easy solutions to get you started in this...
C3 Summit (Conversations on Clinical Content) is part of a series of events that offers sponsors, CROs, and biotech professionals opportunities to share knowledge, gain industry insights, and network. The series has been celebrated for its casual yet informative format and time-efficient, well curated discussions. Previous panels have featured topics such as inclusivity and diversity in patient recruitment, practical applications of AI/ML, regulatory inspection stories and...
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the need for technological innovation in clinical research. The conversation highlights key challenges faced in transitioning from academia to entrepreneurship, and the importance of storytelling in...
Access end-to-end consultation, from licensing to electronic clinical outcome assessment (eCOA) migration, and improve the patient and healthcare provider experience with all types of COAs. ...
Global life sciences companies are realizing the potential artificial intelligence (AI) and machine learning (ML) has to drive efficiency in content and translation management. To capitalize on this, organizations need to identify the right solutions. Discover important considerations for integrating AI and ML into translation management strategies, steps to get started, and a practical use case in this overview....
Accurate and compliant labeling of an investigational medicinal product (IMP) is an important and integral part of clinical trial operations. A misstep in labeling can lead to significant delays, affecting the entire study’s timeline and potentially incurring costs ranging from $100,000 to $700,000 in hard expenses. In worst-case scenarios, incorrect labeling might necessitate a complete product reproduction. Learn more about the strategies and solutions leading sponsors are...
In this webinar, the expert speakers will focus on the critical role of patient communities in advancing clinical trials. They will explore best practices for engaging with patient communities to enhance recruitment, retention and overall success of the trial. Based on case studies and interactive discussions, attendees will learn how to build trust, foster communication and address the unique needs of patient communities. In a recent study, 91 percent of sites stated they...
TransPerfect's experts gather to answer questions from global pharma, biotech, and medical device leaders regarding AI and MT use cases, challenges, opportunities, best practices, and more....
Join us for the OpTImize Summit, Trial Interactive’s exclusive annual customer event. This invitation-only conference features networking opportunities, product showcases, inspiring client success stories, and thought-provoking sessions led by Trial Interactive experts and industry guest speakers. ...
Welcome to TransPerfect Life Sciences' AI and MT Ask an Expert Office Hours. In these sessions, we provide an opportunity for our community to submit their pressing questions for our experts to answer live, in the company of your industry peers. If you are looking for some more insight without spending money or engaging in direct sales conversations, this is a great way to explore some of your most pressing questions....
Study teams who can better anticipate their language needs can better control for the abovementioned pain points. The Ultimate Clinical Trial Translations Checklist was created to help you plan for all your potential language requirements....
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to commercialization. The event offers sponsors, CROs, and biotech professionals opportunities to share knowledge, gain industry insights, and network. Please fill out the form to access the session...
Discover the role of generative artificial intelligence (GenAI) in life sciences, including what is merely a trend vs. what is truly transformative. The speakers will explore pragmatic applications, ethical considerations and the potential future role of generative AI in life sciences, research and development (R&D) and product development. The discussion will provide valuable insights into the ongoing AI revolution within the life sciences sector, including practical...
The European Union's introduction of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) marks a significant shift towards enhanced transparency in the medical device sector. While these regulations are designed to strengthen patient safety following several high-profile device failures, they have also created complex labeling updates and post market reporting requirements. Medical device companies must now navigate these complexities...
